Callan Capital’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $319K | Hold |
101,575
| – | – | 0.02% | 269 |
|
|
2024
Q4 | $441K | Buy |
101,575
+10,108
| +11% | +$43.9K | 0.03% | 198 |
|
|
2024
Q3 | $244K | Buy |
91,467
+26,420
| +41% | +$70.5K | 0.02% | 297 |
|
|
2024
Q2 | $144K | Buy |
65,047
+22,300
| +52% | +$49.5K | 0.01% | 302 |
|
|
2024
Q1 | $228K | Buy |
42,747
+11,600
| +37% | +$61.9K | 0.02% | 255 |
|
|
2023
Q4 | $46.1K | Hold |
31,147
| – | – | ﹤0.01% | 232 |
|
|
2023
Q3 | $43.3K | Buy |
31,147
+17,560
| +129% | +$24.4K | ﹤0.01% | 199 |
|
|
2023
Q2 | $20K | Hold |
13,587
| – | – | ﹤0.01% | 182 |
|
|
2023
Q1 | $22.4K | Hold |
13,587
| – | – | ﹤0.01% | 181 |
|
|
2022
Q4 | $19K | Buy |
+13,587
| New | +$19K | ﹤0.01% | 184 |
|
|
2015
Q3 | – | Sell |
-157
| Closed | -$115K | – | 64 |
|
|
2015
Q2 | $115K | Buy |
+157
| New | +$115K | 0.02% | 66 |
|